Fluorouracilo Hikma

Fluorouracil Hikma is a medication used for certain types of cancer treatments. It is administered intravenously or intraarterially and is manufactured by Hikma Farmacêutica (Portugal), S.A.

Fluorouracil Hikma is primarily used in the treatment of various types of cancer. It works by interfering with the growth of cancer cells, making it effective for conditions where cell growth needs to be controlled. This medication is often prescribed for specific cancer types and should be used under medical supervision.

Common effects of Fluorouracil Hikma may include nausea, vomiting, and fatigue. Some patients might experience hair loss or changes in skin appearance. These effects can vary depending on the individual and the specific treatment plan.

Fluorouracil Hikma should be handled with care and administered by healthcare professionals. It is important to follow the prescribed dosage and monitor for any adverse reactions. Patients should inform their healthcare provider about any pre-existing conditions or allergies before starting treatment.

Fluorouracil Hikma may interact with other medications, including certain chemotherapy drugs and supplements. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be avoided during treatment.